Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer [miRNAseq_exosome]

ABSTRACT: Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer [miRNAseq_exosome]

PROVIDER: PRJNA974401 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24658712.fastq.gz	Fastqsanger.gz
	SRR24658713.fastq.gz	Fastqsanger.gz
	SRR24658714.fastq.gz	Fastqsanger.gz
	SRR24658715.fastq.gz	Fastqsanger.gz
	SRR24658716.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer

Project description:Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer

| PRJNA974391 | ENA

Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer [miRNAseq_exosome]

Project description:Small cell lung cancer (SCLC) has an exceptionally poor prognosis; as most of the cases are initially diagnosed as extensive disease with hematogenous metastasis. Therefore, the early diagnosis of SCLC is very important and may improve its prognosis. To investigate the feasibility of early diagnosis of SCLC, we examined exosomal microRNAs (miRNAs) present in serum obtained from patients with SCLC. Exosomes were isolated in serum from patients with SCLC and healthy individuals and were characterized using particle size and protein markers. Additionally, miRNA array was performed to define SCLC-specific exosomal miRNAs. The miRNAs identified in the miRNA array results were validated using a large cohort. Gene ontology analysis has revealed that a panel of miRNAs are linked to various oncogene pathways and nervous system development. Changes in mRNA expression when target miRNAs were introduced into BEAS2B cells strongly indicated the presence of lung diseases, including lung cancer. Additionally, miRNA panels are significantly associated with poor prognosis. In conclusion, our study identified SCLC-specific exosomal miRNAs, and the miRNAs panel may serve as a diagnostic and prognostic marker for SCLC.

2023-08-31 | GSE232903 | GEO

Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer [mRNAseq_BEAS2B]

2023-08-31 | GSE232904 | GEO

Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer [mRNAseq_BEAS2B]

Project description:Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer [mRNAseq_BEAS2B]

| PRJNA974404 | ENA

Exosomal MicroRNAs Signature Acts as Efficient Biomarker for Non-Invasive Diagnosis of Gallbladder Carcinoma

Project description:Gallbladder carcinoma (GBC) is the most common biliary tract malignant tumor. However, few diagnostic and prognostic biomarkers are available. Although the potential role of exosomes in the diagnosis of several tumor types has been repeatedly explored, the use of exosomal microRNAs (miRNAs) as specific biomarkers for GBC has not been systematically conducted. In this study, we identified a 5-exosomal miRNAs set that can be used to evaluate the risk of GBC through a three-step study that relies on biomarker discovery, training and validation. This biomarker set including the exosomal miR-552-3p, miR-581, miR-4433a-3p, miR-496, and miR-203b-3p.

2022-09-15 | GSE176159 | GEO

Plasma-derived exosomal circular RNA hsa_circ_0005540 as a novel diagnostic biomarker for coronary artery disease

Project description:Aims: Exosomes exist in almost all body fluid and contain diverse biological contents which may be reflective of disease state. Circular RNAs (CircRNAs) are stable in structure and have a long half-life in exosomes without degradation, thus making them reliable biomarkers. However, the potential of exosomal circRNAs as biomarkers of coronary artery disease (CAD) remains to be established. Here we aimed to investigate the expression levels and the potential use of exosomal circRNAs as diagnostic biomarkers of CAD. Main methods: CircRNAs expression levels in exosomes obtained from three plasma samples from CAD patients and three paired controls were analyzed using RNA sequencing. Exosomal circRNAs obtained in the profiling phase were then verified in two-center validation cohorts. Finally, the ability of exosomal circRNAs, adjusting for Framingham Heart Study (FHS) risk factors, was determined to discriminate between CAD patients and non-CAD controls. Key findings: 355 circRNAs were differentially expressed between these two groups: 164 were upregulated, and 191 were downregulated. Here we selected potential circRNAs (fold change > 4, P < 0.05) as candidate biomarkers for further validation. Our data showed that only hsa_circ_0005540 was significantly associated with CAD (P < 0.0001). After adjustment for risk factors, hsa_circ_0005540 showed a high discriminatory power for CAD in ROC analyses (AUC = 0.853; 95% confidence interval [CI] = 0.799 - 0.906, P < 0.001). Significance: Our results suggest that plasma exosomal hsa_circ_0005540 can be used as a promising diagnostic biomarker of CAD.

2020-07-20 | GSE152498 | GEO

Exosomal miR-92a-3p as a diagnostic biomarker for adenomyosis and its pathological mechanism

Project description:This study aimed to elucidate the role of microRNA miR-92a-3p in the pathogenesis of adenomyosis. We focused on understanding how miR-92a-3p in exosomes derived from ectopic lesions influences the behavior of endometrial cells, DRG neurons, and Human Umbilical Vein Endothelial Cells (HUVECs), and its potential as a non-invasive diagnostic biomarker. Our findings revealed that MiR-92a-3p is significantly upregulated in exosomes derived from ectopic lesions of adenomyosis. This upregulation was associated with enhanced migration and invasion capabilities in eutopic endometrial cells, DRG neurons, and HUVECs. Furthermore, the study demonstrated a significant correlation between the levels of MiR-92a-3p in urinary exosomes and the clinical symptoms of adenomyosis, suggesting its potential as a non-invasive biomarker for the disease. This study elucidates an exosomal signaling process via miR-92a-3p that drives pathological infiltration and angiogenesis to promote adenomyosis progression. Upregulated miR-92a-3p in biofluid exosomes shows promising non-invasive biomarker potential for diagnosis and monitoring of this disease. Our findings unveil novel targets and tools for improved clinical management.

2024-04-01 | GSE262302 | GEO

Exosomal miR-92a-3p as a diagnostic biomarker for adenomyosis and its pathological mechanism

Project description:Exosomal miR-92a-3p as a diagnostic biomarker for adenomyosis and its pathological mechanism

| PRJNA1091186 | ENA

Development of a two-circular RNA panel as potential prognostic biomarker for gastric cancer

Project description:Development of a two-circular RNA panel as potential prognostic biomarker for gastric cancer

| PRJNA753325 | ENA

Diagnostic value of a panel of plasma exosomal miRNAs as potential biomarkers for thyroid nodules

Project description:Diagnostic value of a panel of plasma exosomal miRNAs as potential biomarkers for thyroid nodules

| PRJNA540503 | ENA